Skip to content
The Policy VaultThe Policy Vault

TracleerMedical Mutual

Chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group 4

Initial criteria

  • The request is for bosentan (Tracleer, generic); AND
  • The medication is prescribed by or in consultation with a cardiologist or pulmonologist; AND
  • Patient has tried Adempas; OR use of Adempas is contraindicated; OR patient is currently receiving bosentan; AND
  • The patient has been treated surgically or CTEPH is inoperable; AND
  • For brand Tracleer, the patient has failed a trial of generic bosentan and/or the patient cannot take generic bosentan due to a formulation difference in the inactive ingredient(s) which would result in a significant allergy or serious adverse reaction per the prescribing physician

Approval duration

1 year